SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron

With the emergence of the SARS-CoV-2 Omicron variant in late 2021, Canadian public health case/contact testing was scaled back due to high infection rates with milder symptoms in a highly vaccinated population. We monitored the seroprevalence of SARS-CoV-2 nucleocapsid (anti-N) and spike protein (an...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Brien, Sheila F., Caffrey, Niamh, Yi, Qi-Long, Pambrun, Chantale, Drews, Steven J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695729/
https://www.ncbi.nlm.nih.gov/pubmed/36366432
http://dx.doi.org/10.3390/v14112336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695729/
https://www.ncbi.nlm.nih.gov/pubmed/36366432
http://dx.doi.org/10.3390/v14112336

Ejemplares similares